The most comprehensive whole exome panel that covers the target regions of all major WES panels in the market. With our proprietary technologies, we provide industry-leading performance and efficiency with complete BI solution.
View Detail >
Hybridization-based target enrichment panel with our intrinsic probe design, rebalancing, and molecular barcode technologies to efficiently analyze not only hard-to-capture areas but also challenging samples, such as damaged DNA or RNA.
View Detail >
End-to-end customized target enrichment panel with assay optimization, validation and even complete BI support. Over 1,000 custom panels developed world-wide. White-labeled customized product for business expansion also available.
View Detail >The most comprehensive whole exome panel that covers the target regions of all major WES panels in the market. With our proprietary technologies, we provide industry-leading performance and efficiency with complete BI solution.
View Detail >The most comprehensive whole exome panel that covers the target regions of all major WES panels in the market. With our proprietary technologies, we provide industry-leading performance and efficiency with complete BI solution.
View Detail >End-to-end customized target enrichment panel with assay optimization, validation and even complete BI support. Over 1,000 custom panels developed world-wide. White-labeled customized product for business expansion also available.
View Detail >
Providing NGS-based diagnostics solutions for biopharma companies. Celemics can develop and deliver a flexible customization and commercialization services while maintaining the market-leading performance for our clients interested in clinical and companion diagnostics.
View Detail >
Tailored-fit customized assay development from designing to validation run; including not only the custom panel design but also species-specific or sequencer-specific blockers, followed by reagent conditioning to optimize the individual experiment and sequencer.
View Detail >The most comprehensive whole exome panel that covers the target regions of all major WES panels in the market. With our proprietary technologies, we provide industry-leading performance and efficiency with complete BI solution.
View Detail >
Find useful information, insights and tools for your Celemics’ products and services
View Detail >
Explore the most up-to-date publications featuring Celemics’ products and services
View Detail >
Sharing interesting stories about the world of NGS and how Celemics delivers the innovative NGS solutions to the world of science.
View Detail >
Explore a diverse range of engaging video content, from fascinating experiments showcasing cutting-edge research to heartfelt customer testimonials.
View Detail >Find useful information, insights and tools for your Celemics’ products and services
View Detail >
Stay up-to-date with the latest updates on our activities, events and achievements
View Detail >
Let’s change the NGS market together – our global presence and partners world-wide
View Detail >
Waiting for your experience with Celemics, an innovative leader in NGS industry
View Detail >Oncology
Molecular Cancer Distant origin of glioblastoma recurrence: neural stem cells in the subventricular zone serve as a source of tumor reconstruction after primary resection Li, X., Kim, H. J., Yoo,…
Frontiers in Oncology The clinical relevance of surgical specimens for RNA sequencing in lung cancer: a cohort study Eom, J. S., Kim, S. H., Kim, K., Kim, A., Ahn, H.…
Cancer Research and Treatment Varlitinib and Paclitaxel for EGFR/HER2 Co-Expressing Advanced Gastric Cancer: A Multicenter Phase Ib/II Study (K-MASTER-13) Koo DH, Jung M, Kim YH, Jeung HC, Zang DY, Bae…
Cancers Discovery and Validation of Survival-Specific Genes in Papillary Renal Cell Carcinoma Using a Customized Next-Generation Sequencing Gene Panel Hwang J, Bang S, Choi MH, Hong SH, Kim SW, Lee…
Frontiers in Neurology Case report: Compound heterozygous variants detected by next-generation sequencing in a Tunisian child with ataxia-telangiectasia Ammous-Boukhris N, Abdelmaksoud-Dammak R, Ben Ayed-Guerfali D, Guidara S, Jallouli O, Kamoun…
Scientific Reports Sex-specific survival gene mutations are discovered as clinical predictors of clear cell renal cell carcinoma Hwang J, Lee HE, Han JS, Choi MH, Hong SH, Kim SW, Yang…
Scientific Reports Human epidermal growth factor receptor-2 expression and subsequent dynamic changes in patients with ovarian cancer Kim Y-N, Chung YS, Park E, Lee ST, Lee J-Y. Human epidermal growth…
Translational Lung Cancer Research Predicting disease recurrence in limited disease small cell lung cancer using cell-free DNA-based mutation and fragmentome analyses Park S, Kang J-K, Lee N, Lee S-H, Kim…
Turk J Gastroenterol Clinical and Molecular Analysis in Patients with Peutz-Jeghers Syndrome Aslan PG, Çağlayan AO, Bora E, Koç A, Yucel H, Ülgenalp A, et al. Clinical and molecular analysis…
Journal of Gynecologic Oncology Application of precision medicine based on next-generation sequencing and immunohistochemistry in ovarian cancer: a real-world experience Kim Y-N, Chung YS, Lee JH, Park E, Lee S-T,…
